HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 39 filers reported holding HEPION PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $23,000 | -95.9% | 20,479 | -93.3% | 0.00% | -97.3% |
Q1 2021 | $564,000 | +216.9% | 306,338 | +434.5% | 0.11% | +307.4% |
Q3 2020 | $178,000 | +39.1% | 57,309 | -21.0% | 0.03% | -49.1% |
Q1 2020 | $128,000 | -54.0% | 72,575 | -36.9% | 0.05% | -64.7% |
Q3 2019 | $278,000 | – | 115,000 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 923,230 | $2,022,000 | 0.82% |
Worth Venture Partners, LLC | 233,947 | $512,000 | 0.40% |
PERKINS CAPITAL MANAGEMENT INC | 150,000 | $329,000 | 0.22% |
GSA CAPITAL PARTNERS LLP | 89,067 | $195,000 | 0.03% |
PREMIER ASSET MANAGEMENT LLC | 70,000 | $153,000 | 0.03% |
Allen Capital Group, LLC | 23,685 | $52,000 | 0.01% |
ZEKE CAPITAL ADVISORS, LLC | 50,000 | $110,000 | 0.01% |
Prospera Financial Services Inc | 39,300 | $86,000 | 0.01% |
Onex Canada Asset Management Inc. | 20,000 | $44,000 | 0.00% |
Schonfeld Strategic Advisors LLC | 95,300 | $208,000 | 0.00% |